***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Hi David,
Have you tried Resolve with the prime and switch command? We found it very useful to get really nice phases in an MR involving a search model in the sub-30 percent sequence overall identity range using 3Å data. Just make sure to define the intial NCS and adjust the input mtz following the nice intructions on Terwilligers home page. An additional approach that you might already have tried, at this resolution, is to ARP/wARP the MR solution to death.

Good luck!!!

Karl-Magnus Larsson

david lawson (JIC) wrote:

***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***


Dear All,

We are having a lot of trouble with a particularly awkward protein and
would be extremely grateful for any helpful suggestions.

The protein appears to be a tetramer of 30 kDa subunits, as judged by
dynamic light scattering and gel filtration, and so far we have obtained
two crystal forms.
Crystal form 1 - processes nicely as C2 with the following cell
parameters: a = 86.5, b = 139.2, c = 100.7 Ang, beta = 101.6 deg. We
have collected complete data to 2.1 Ang resolution. We estimate a
solvent content of 50% for one tetramer per ASU.
Crystal form 2 - processes equally well as rhombohedral, I centred
tetragonal or F centred cubic (at the end of this message I have given a
typical autoindexing run from Denzo). The crystals diffract strongly to
at least 2 Ang resolution, but data collection much beyond 2.5 Ang
in-house is difficult because of the long cell parameters. If the data
are processed as F432, for example, this gives a solvent content of 65%
for one tetramer per ASU.

So far we have a molecular replacement solution for xtal form 1 that I
think is essentially correct, as it gives sensible packing and a NCS
4-fold that is consistent with a peak in a self-rot function. However,
the calculated phases are very poor because the template structure
represents only about 65% of the target structure and the sequence
identity is in the low 20s (the template was produced using CHAINSAW).
Refinement on the structure beyond fitting in AMORE seems to make things
worse. Running DM with 4-fold averaging seems to help, but the maps are
heavily biased. I have taken advice from Kevin on which recipes to use,
but so far have seen little improvement. My feeling is that if we could
somehow refine the AMORE solution without it falling apart, perhaps we
could get a better set of input phases for DM - any ideas here?

Molecular replacement with data from xtal form 2 in a variety of space
groups, doesn't yield any sensible solutions. We have some "derivative"
data at 2.2 Ang resolution from crystals grown using tungstate as the
precipitant. These were collected at the W L1 edge and appear to show a
very significant anomalous signal. Eleanor took a look at these data
(processed as F432) and found a native Patterson peak at 1/4,1/4,1/4,
suggesting 2 molecules per ASU (this would give a solvent content of
30%). She also found 2 heavy atom sites with SHELX at 1/2,0,0 and the
related 3/4,1/4,1/4, but these are not much use for anomalous phasing.
Perhaps the anomalous signal is due to a lot of low occupancy binding
sites. BTW, the data seem to pass all the tests in TRUNCATE for not
being twinned. Any advice here would be appreciated.

Clearly, working with xtal form 1 is the most straightforward, but if we
can get some phase info for xtal form 2, then cross-xtal averaging
becomes a possibility. Unfortunately, now we can only get crystals of
form 2. Also the structure is unlikely to have any ordered Mets, so we
have introduced 3 - now we can't get soluble Se-Met protein - but that's
another story! Any helpful suggestions gratefully received.
Many thanks,

Dave Lawson


--
______________________________________

Karl-Magnus Larsson, Ph.D.

Department of Structural Biology
Stanford University School of Medicine
Fairchild Science Building D122
Stanford, CA 94305-5126
USA
Tel: 650-724-9944

Reply via email to